(NYSE: RMD) Resmed's forecast annual earnings growth rate of 7.93% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 17.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.
Resmed's earnings in 2025 is $1,313,254,000.On average, 8 Wall Street analysts forecast RMD's earnings for 2025 to be $1,392,593,722, with the lowest RMD earnings forecast at $1,375,365,003, and the highest RMD earnings forecast at $1,428,150,866. On average, 8 Wall Street analysts forecast RMD's earnings for 2026 to be $1,519,983,606, with the lowest RMD earnings forecast at $1,425,218,318, and the highest RMD earnings forecast at $1,580,643,361.
In 2027, RMD is forecast to generate $1,648,091,965 in earnings, with the lowest earnings forecast at $1,563,048,073 and the highest earnings forecast at $1,722,871,938.